FORA Capital LLC Buys Shares of 66,406 DENTSPLY SIRONA Inc. $XRAY

Key Points

• FORA Capital LLC purchased 66,406 shares of DENTSPLY SIRONA Inc. valued at approximately $992,000, marking the firm's new position in the company.
• Analysts have recently revised their ratings, with some downgrading DENTSPLY SIRONA to a "hold" status while others have set a price target range between $15.00 and $24.00.
• The company reported a quarterly earnings per share (EPS) of $0.52, exceeding estimates, but recorded a 4.9% decline in year-over-year revenue.

FORA Capital LLC acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 66,406 shares of the medical instruments supplier's stock, valued at approximately $992,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of DENTSPLY SIRONA by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier's stock valued at $309,864,000 after purchasing an additional 557,329 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in DENTSPLY SIRONA by 11.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier's stock worth $208,590,000 after buying an additional 1,412,517 shares during the period. Fuller & Thaler Asset Management Inc. lifted its stake in DENTSPLY SIRONA by 4.7% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier's stock valued at $180,445,000 after buying an additional 538,531 shares during the last quarter. Lazard Asset Management LLC lifted its stake in DENTSPLY SIRONA by 23.0% in the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier's stock valued at $152,678,000 after buying an additional 1,505,928 shares during the last quarter. Finally, AQR Capital Management LLC boosted its holdings in shares of DENTSPLY SIRONA by 245.1% in the fourth quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier's stock valued at $54,389,000 after acquiring an additional 2,054,767 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY traded down $0.49 during mid-day trading on Tuesday, reaching $13.81. The stock had a trading volume of 3,060,167 shares, compared to its average volume of 3,670,340. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.48. The business has a 50 day simple moving average of $15.09 and a 200 day simple moving average of $15.29. The firm has a market capitalization of $2.75 billion, a price-to-earnings ratio of -2.91, a PEG ratio of 0.89 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The business had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same period in the prior year, the business posted $0.49 EPS. The company's revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.6%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's payout ratio is presently -13.50%.

Analysts Set New Price Targets

XRAY has been the topic of a number of recent research reports. Stifel Nicolaus cut their target price on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a report on Friday, August 8th. Barrington Research dropped their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. UBS Group decreased their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Wells Fargo & Company lowered their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a report on Friday, August 8th. Finally, Wall Street Zen cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Two research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of "Hold" and a consensus target price of $18.64.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.